PRO 542

· Progenics Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO 542, covering 2008-10-03 to 2008-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients [Phase 2]